aspartic acid has been researched along with Carcinoma, Ductal, Pancreatic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abrego, J; Betts, CB; Bhattacharyya, S; Coussens, LM; Diaz, L; Nagarajan, S; Oon, C; Sandborg, H; Sanford-Crane, H; Sherman, MH; Sun, D; Tontonoz, P; Xia, Z; Xiao, X | 1 |
| Cole, G; Gabrail, NY; James, D; Khorana, AA; Ramanathan, RK; Shah, S; Thomas, GW; Wong, S; Zhou, C | 1 |
| Abt, ER; Armstrong, WR; Cabebe, AE; Capri, JR; Dann, AM; Donahue, TR; Elliott, IA; Ghukasyan, R; Kim, SS; Kim, W; Le, TM; Li, L; Matsumura, C; Moore, A; Poddar, S; Radu, CG; Tucker, DA; Williams, JL; Wu, N; Xu, S; Zhou, L | 1 |
| Guan, KL; Lin, H; Ling, ZQ; Shi, Q; Xiong, Y; Yang, H; Yang, Y; Ye, D; Zhang, M; Zhao, S; Zhao, Y; Zhou, L | 1 |
| Bell, KM; Chung, CH; Gu, G; Means, AL; Ray, KC; Washington, MK; Yan, J | 1 |
| Abbruzzese, JL; Bondy, ML; Evans, DB; Hassan, MM; Jiao, L; Li, D | 1 |
1 trial(s) available for aspartic acid and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Benzimidazoles; Blood Coagulation; Carcinoma, Pancreatic Ductal; Deoxycytidine; Drug Monitoring; Factor VIIa; Female; Gemcitabine; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Pancreatic Neoplasms; Progression-Free Survival; Time Factors | 2019 |
5 other study(ies) available for aspartic acid and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
A Cancer Cell-Intrinsic GOT2-PPARĪ“ Axis Suppresses Antitumor Immunity.
Topics: Aspartate Aminotransferases; Aspartic Acid; Carcinoma, Pancreatic Ductal; Fatty Acids; Humans; Ligands; Malates; Pancreatic Neoplasms; PPAR delta; Tumor Microenvironment | 2022 |
Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion.
Topics: Animals; Aspartic Acid; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Chloroquine; Female; Humans; Lysosomes; Male; Mice; Mitochondria; Pancreatic Neoplasms; Stress, Physiological; Xenograft Model Antitumor Assays | 2019 |
SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth.
Topics: Acetylation; Animals; Aspartate Aminotransferase, Mitochondrial; Aspartic Acid; Biological Transport; Carcinoma, Pancreatic Ductal; Cell Proliferation; Cells, Cultured; HEK293 Cells; Humans; Malates; Male; Mice; Mice, Inbred C57BL; Mice, Nude; NAD; Oxidation-Reduction; Pancreatic Neoplasms; Protein Processing, Post-Translational; Sirtuin 3 | 2015 |
Epithelial tissues have varying degrees of susceptibility to Kras(G12D)-initiated tumorigenesis in a mouse model.
Topics: Amino Acid Substitution; Animals; Aspartic Acid; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Cell Transformation, Neoplastic; Disease Models, Animal; Disease Susceptibility; Epithelium; Glycine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mouth Neoplasms; Mutation, Missense; Pancreatic Neoplasms; Papilloma; Proto-Oncogene Proteins p21(ras) | 2011 |
The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk.
Topics: Adenocarcinoma; Aged; Amino Acid Substitution; Asparagine; Aspartic Acid; Carcinoma, Pancreatic Ductal; Case-Control Studies; Female; Gene Frequency; Genotype; Glutamine; Haplotypes; Humans; Linkage Disequilibrium; Lysine; Male; Middle Aged; Pancreatic Neoplasms; Polymorphism, Single Nucleotide; Risk Factors; Smoking; Xeroderma Pigmentosum Group D Protein | 2007 |